Purchase Order 75N94019P00731

Award Date 8/15/19
Potential Completion Date 11/15/19
Potential Value $36K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Spain
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $50,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to the prime contractor Entrechem SL. The contract is for the purchase of 100 grams each of two specific enantiomers of trans-N-Boc-1,2-tetrahydro-3,4-furandiamine. These chemical compounds are needed as starting materials for the NIDDK's research into developing thyclotides, which...
This is a $40,500 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Polyorg, Inc., a for-profit manufacturer located in Leominster, MA. The order is for specialized chemical reagents including Fmoc-PNA monomers and Bhoc Nucleobase Acids, which are essential starting materials for NIDDK's research on thyclotides - molecules with potential diagnostic applications. The purchase order was awarded on a sole-source basis under...
This federal contract award, valued at $51,248.00, was issued by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Polyorg, Inc., a manufacturer of specialty chemicals. The award was a firm fixed-price purchase order for the delivery of 80 grams of A(Bhoc)-OH, 120 grams of C(Bhoc)-OH, and 160 grams of G(Bhoc)-OH, which are key building blocks for the development of thyclotides and cyclopentane peptide nucleic acids. These materials...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $19,800 firm fixed price purchase order to Karebay Biochem Inc., a for-profit small business, to synthesize 200 grams of compound NCGC00413972. This order supports NIH's biomedical research programs, particularly in the areas of drug discovery and infectious disease. Karebay Biochem has received multiple prior purchase orders from NIH entities to...
This is a $21,296 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services (HHS), to Enamine US Inc. for a set of compounds/molecules. The contract has no set-aside designation. Enamine US Inc. is a for-profit organization that provides chemical compounds and research services to support pharmaceutical, biotechnology, and other life science companies and research organizations....
This is a $27,384.76 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of 3 batches/shipments of 60 units each of the intravenous stable isotope D5 glycerol, which is required for metabolic research studies conducted...
This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...
<p>This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Asischem Inc. for the custom synthesis of Compound 8 for Robert Cragie, Building 5 Room 439. The contract has a ceiling value of $14,997.00 and was awarded on September 28, 2007, with an ultimate completion date of October 14, 2007. The contract does not have a set-aside designation.</p>
This is a firm fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services (HHS), to American Biochemicals Inc. The contract is for the provision of 1 gram of ML246 (metarrestin) compound for $86,000.00. The contract does not have a set-aside designation. American Biochemicals Inc. is a minority-owned, small disadvantaged business that specializes in small molecule design, optimization,...

This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting materials for the development of cyclopentane peptide nucleic acid (cyPNA) probes, which have potential applications in diagnostic tests for infections and diseases. The contract does not have a set-aside designation and was awarded via a sole-source purchase order in support of NIDDK's research mission.

Generated 1/17/25, 9:27 AM